Pharmaceuticals

Drug Development Biotechnology Drug Pricing Acquisitions Manufacturing Drug Manufacturing Vaccine Development Market Competition Market Trends Mergers and Acquisitions

6 ARTICLES

13h ago

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Backed by a $650 million up-front payment, the agreement places Pfizer in charge of global development for a 12-program cancer portfolio discovered and advanced by Innovent.

6 ARTICLES

22h ago

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

Stories older than 24h

3 ARTICLES

yesterday

FDA Approves Durvalumab Plus BCG for High‑Risk Non‑Muscle Invasive Bladder Cancer

4 ARTICLES

yesterday

Pfizer Moves 25-Valent Infant Pneumococcal Shot Into Late-Stage Trial After Mid-Stage Gains

3 ARTICLES

last wk.

Jury Finds Takeda Liable for Delaying Amitiza Generics, Awards $885 Million

3 ARTICLES

last wk.

FDA Clears First Biosimilars to Simponi and Simponi Aria: IMMGOLIS and IMMGOLIS INTRI

4 ARTICLES

2w ago

Merck KGaA Raises 2026 Profit Outlook After Q1 Beat

6 ARTICLES

2w ago

United Therapeutics Teams With Varda to Test Space-Made Drug Formulations

3 ARTICLES

2w ago

Verrica Reports $5 Million Q1 Revenue as Wycanth Grows and Phase 3 Wart Program Advances

7 ARTICLES

2w ago

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

7 ARTICLES

2w ago

Moderna Jumps on Hantavirus Cruise-Ship Cluster as U.S. Repatriates 17 Citizens

6 ARTICLES

3w ago

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion in Cash

5 ARTICLES

3w ago

Mounjaro Overtakes Keytruda as World’s Best-Selling Drug in Q1 2026

8 ARTICLES

3w ago

Eli Lilly Pours $4.5 Billion Into Indiana Plants, Opens Genetic-Medicine Site

17 ARTICLES

3w ago

Novo Nordisk Lifts Outlook After Wegovy Pill Fuels Q1 Beat

5 ARTICLES

3w ago

Pharmaceuticals

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

FDA Approves Durvalumab Plus BCG for High‑Risk Non‑Muscle Invasive Bladder Cancer

NeuroThera Wins Conditional TSX Approval to Acquire CliniQuantum

Novo Nordisk Narrows Gap With Lilly as Wegovy Pill Leads Early Oral Sales

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

Lilly Acquires Engage Biologics for Up to $202 Million

Pfizer Moves 25-Valent Infant Pneumococcal Shot Into Late-Stage Trial After Mid-Stage Gains

Jury Finds Takeda Liable for Delaying Amitiza Generics, Awards $885 Million

FDA Clears First Biosimilars to Simponi and Simponi Aria: IMMGOLIS and IMMGOLIS INTRI

Never miss stories about

Pharmaceuticals

Merck KGaA Raises 2026 Profit Outlook After Q1 Beat

United Therapeutics Teams With Varda to Test Space-Made Drug Formulations

Verrica Reports $5 Million Q1 Revenue as Wycanth Grows and Phase 3 Wart Program Advances

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

Moderna Jumps on Hantavirus Cruise-Ship Cluster as U.S. Repatriates 17 Citizens

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion in Cash

Mounjaro Overtakes Keytruda as World’s Best-Selling Drug in Q1 2026

Eli Lilly Pours $4.5 Billion Into Indiana Plants, Opens Genetic-Medicine Site

Novo Nordisk Lifts Outlook After Wegovy Pill Fuels Q1 Beat

Oscar Health Reports Record $679 Million Q1 Profit on ACA Membership Surge

Never miss stories about

Pharmaceuticals